Showing results (11-20 of 615) with videos related to

Sort By:
Pageof 62
Plos Medicine|January 13, 2006
Viable group A streptococci in macrophages during acute soft tissue infectionPontus Thulin, Linda Johansson, Donald E Low, et al.
CJEM|July 14, 2007
Necrotizing pneumonia and septic shock: suspecting CA-MRSA in patients presenting to Canadian emergency departmentsJoseph V Vayalumkal, Heather Whittingham, Otto Vanderkooi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2002
Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996Abdu Sharkawy, Donald E Low, Raphael Saginur, et al.
Antimicrobial Agents and Chemotherapy|June 2, 2011
Susceptibility of Streptococcus pneumoniae to fluoroquinolones in CanadaSamir N Patel, Allison McGeer, Roberto Melano, et al.
Archives of Internal Medicine|February 18, 2003
Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, CanadaMatthew P Muller, Donald E Low, Karen A Green, et al.
Chest|December 15, 2006
Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICUSangeeta Mehta, Allison McGeer, Donald E Low, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Distribution of antiseptic resistance genes qacA, qacB, and smr in methicillin-resistant Staphylococcus aureus isolated in Toronto, Canada, from 2005 to 2009Jean Longtin, Christine Seah, Krystal Siebert, et al.
Emerging Infectious Diseases|March 1, 2007
Methicillin-resistant Staphylococcus aureus colonization in veterinary personnelBeth A Hanselman, Steve A Kruth, Joyce Rousseau, et al.
Antimicrobial Agents and Chemotherapy|March 9, 2011
Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapyJean Longtin, Christie Vermeiren, Dea Shahinas, et al.
Scandinavian Journal of Infectious Diseases|April 26, 2005
Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approachAnna Norrby-Teglund, Matthew P Muller, Allison Mcgeer, et al.
Pageof 62